Global Orthopedic Devices Market - 2025-2033

The global orthopedic devices market reached US$ 58.56 billion in 2024 and is expected to reach US$ 86.56 billion by 2033, growing at a CAGR of 4.1% during the forecast period 2025-2033.

Orthopedic devices are specialized medical equipment used to treat, support, and replace musculoskeletal system components such as bones, joints, and soft tissues. These devices are essential for controlling a wide range of problems caused by trauma, congenital abnormalities, or degenerative diseases. They are vital in both surgical and non-surgical treatments, allowing patients with musculoskeletal problems to heal more quickly and improve their quality of life. In addition to physical support, orthopedic devices can considerably enhance patient outcomes by shortening recovery durations and increasing rehabilitation processes. Especially after surgeries involving joint replacements or fracture fixations, patients frequently rely on these devices during their recovery period to guarantee appropriate healing and prevent problems.

The increasing prevalence of orthopedic disorders is the driving factor that drives the market over the forecast period. For instance, according to the National Institute of Health, In the United States, ten million people over the age of fifty suffer from hip osteoporosis. An additional 33.6 million people over the age of 50 have low bone mass or osteopenia of the hip, putting them at risk for osteoporosis and associated problems later in life.

Market Dynamics: Drivers & Restraints

Increasing prevalence of orthopedic disorders

The increasing prevalence of orthopedic disorders is expected to be a significant factor in the growth of the global orthopedic devices market. The global orthopedic devices market is poised for significant expansion, owing mostly to the rising prevalence of orthopedic diseases. These disorders, which include a wide spectrum of problems affecting the musculoskeletal system, have emerged as a major public health concern due to their increasing prevalence and the corresponding economic impact on healthcare systems around the world. Due to the increasing number of orthopedic disorders, the demand for orthopedic devices increases.

For instance, according to the World Health Organization, rheumatoid arthritis affects around 18 million people globally. Women account for around 70% of those with rheumatoid arthritis, with 55% being over the age of 55. Rheumatoid arthritis affects 13 million people, with varying degrees of severity. In order, to reduce the increasing prevalence of orthopedic diseases, major manufacturers have launched orthopedic devices that are useful in the treatment of various orthopedic disorders. For instance, in February 2023, CurvaFix, Inc., a manufacturer of medical devices that repair fractures in bent bones, announced the release of its smaller-diameter, 7.5mm CurvaFix IM Implant, which is intended to simplify surgery and give strong, stable fixation in small-bone patients.

Robotic procedures, computer-assisted surgical techniques, and the discovery of biocompatible materials have transformed the orthopedic landscape. These developments improve not only surgical precision but also patient outcomes and recuperation timelines. As healthcare providers adopt these new technologies, they will be better prepared to meet the growing need for orthopedic solutions.

High costs of devices

Factors such as high costs of devices are expected to hamper the global orthopedic devices market. The worldwide orthopedic devices market meets significant challenges, particularly given the high cost of these medical technologies. The development, production, and marketing of orthopedic devices require significant expenditure, resulting in higher prices for end users. This price burden might limit patient's access to required therapies, particularly in low-income areas where healthcare funds are limited. For instance, according to the National Institute of Health, the costs of implants range from $350 to $6,370 right from the basic device to advanced versions. The average per-case cost for an implant was $2,817 (range $1,250 to $7,270).

Segment Analysis

The global orthopedic devices market is segmented based on product type, application, end-user, and region.

Orthopedic braces segment is expected to dominate the global orthopedic devices market share

The orthopedic braces segment is anticipated to dominate the global orthopedic devices market owing to its essential function in several applications across diverse scientific fields. The orthopedic braces sector is anticipated to dominate the worldwide orthopedic devices market, owing to a number of important factors including rising demand for these devices and their critical role in patient care, technological advances, and new product launches. The increasing prevalence of orthopedic diseases, such as arthritis, osteoporosis, and sports-related injuries, has created a greater demand for appropriate support and stabilization solutions.

For instance, according to the International Osteoporosis Foundation, Osteoporosis is predicted to impact 200 million women worldwide, roughly one-tenth of women aged 60, one-fifth of women aged 70, two-fifths of women aged 80, and two-thirds of women aged 90. Furthermore, technological developments in materials and technology have significantly enhanced the functionality and comfort of orthopedic braces. Lightweight materials, customized fits, and integrated support systems have increased the appeal of these devices to patients and healthcare providers. There are recent launches in which the latest technology is being involved in the device. For instance, in August 2024, Aspen Medical Products introduced the Align Orthosis. Align Orthosis, developed in partnership with spine surgeon Han Jo Kim, MD of the Hospital for Special Surgery, is the first prefabricated TLSO designed to reduce the incidence of proximal junctional kyphosis (PJK) after surgery.

Geographical Analysis

North America is expected to hold a significant position in the global orthopedic devices market share

North America is expected to hold a significant portion of the global orthopedic devices market. North America will likely account for a significant share of the global orthopedic devices market, owing to its well-established healthcare infrastructure, high demand for novel medical devices, and an increasing patient population requiring orthopedic procedures. As osteoarthritis and osteoporosis become more frequent, the demand for effective orthopedic solutions continues to increase, boosting market expansion in this region.

For instance, according to the Bone Health and Osteoporosis Foundation, approximately 10 million Americans have osteoporosis and another 44 million have low bone density, placing them at increased risk. 54 million Americans, half of all adults age 50 and older, are at risk of breaking a bone. One in two women and up to one in four men will break a bone in their lifetime due to osteoporosis. For women, the incidence is greater than that of heart attack, stroke, and breast cancer combined. Moreover, according to John Hopkins Medicine, 30% of Caucasian postmenopausal women in the United States have osteoporosis, while 54% have osteopenia. The incidence of deficient bone mass rises with age.

The presence of major players in this region, recent product launches, and FDA approvals make North America hold the highest market share. For instance, in October 2024, Smith+Nephew announced that it had launched its Legion-hinged knee (HK) system with Oxinium implant technology in the United States. This implant technology outperforms both metal durability and ceramic wear resistance, as well as corrosion resistance.

Asia Pacific is growing at the fastest pace in the global orthopedic devices market

The Asia Pacific region is emerging as the fastest-growing market for orthopedic devices, owing to a combination of demographic trends, increased healthcare investment, recent launches, and an increasing prevalence of orthopedic diseases. This growth is largely attributed to the rapid increase in the aging population across countries like China and India, where the demand for orthopedic interventions is surging due to age-related conditions such as osteoarthritis and osteoporosis.

For instance, according to the World Health Organization (WHO), 30% of postmenopausal women suffer from osteoporosis. It has been reported that around six crore people in India have osteoporosis and 80% of them are women. The peak incidence of osteoporosis in India occurs 10 - 20 years earlier than in Western countries.

Competitive Landscape

The major global players in the global orthopedic devices market include Stryker Corporation, Zimmer Biomet, Synthes Inc., Sonoma Orthopaedic Products Inc., Medtronic, Wright Medical Group N.V, Orthofix Medical Inc., Integra LifeSciences, Arthrex Inc., Smith & Nephew plc. among others.

Emerging Players

Stoko, Canary Medical, and Loci Orthopedics among others

Key Developments

• In March 2024, Stryker, a global leader in medical technologies, announced the release of its Gamma4 Hip Fracture Nailing System in most of the European markets. The newest Gamma system will provide surgeons with the next generation of Stryker's intramedullary nailing system. The Gamma4 system is designed to treat hip and femur fractures and streamline procedural workflows for surgeons.
• In October 2023, DePuy Synthes, the orthopedic device business of Johnson & Johnson, has won FDA 510(k) clearance for its TriLeap lower extremity anatomic plating system. TriLeap offers a wide range of plate options tailored for various procedures and screw diameters, according to DePuy Synthes. Its instruments can be used during the reduction, internal fixation, and fusion of bones and bone fragments.
• In August 2023, Enovis Corp. acquired Novastep SAS and its foot and ankle minimally invasive surgical (MIS) platform from Amplitude Surgical SAS for €68 million.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global orthopedic devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.